Abstract: Described are novel nicotine-binding antibodies and methods of using them for treating nicotine addiction and/or facilitating smoking cessation, or for treating nicotine overdose or nicotine poisoning.
Type:
Application
Filed:
August 12, 2022
Publication date:
March 23, 2023
Applicants:
ANTIDOTE THERAPEUTICS, INC., BliNK BIOMEDICAL, Hennepin Healthcare Research Institute
Inventors:
Matthew W. KALNIK, Thomas THISTED, Nicola BELTRAMINELLI, Stéphanie FALLOT, Zuzana BIESOVA, Steve FULLER, Mark G. LeSAGE, Paul PENTEL
Abstract: Described are novel nicotine-binding antibodies and methods of using them for treating nicotine addiction and/or facilitating smoking cessation, or for treating nicotine overdose or nicotine poisoning.
Type:
Grant
Filed:
August 14, 2018
Date of Patent:
September 13, 2022
Assignees:
ANTIDOTE THERAPEUTICS, INC., BliNK BIOMEDICAL, Hennepin Healthcare Research Institute
Inventors:
Matthew W. Kalnik, Thomas Thisted, Nicola Beltraminelli, Stéphanie Fallot, Zuzana Biesova, Steve Fuller, Mark G. Lesage, Paul Pentel
Abstract: Described are novel nicotine-binding antibodies and methods of using them for treating nicotine addiction and/or facilitating smoking cessation, or for treating nicotine overdose or nicotine poisoning.
Type:
Application
Filed:
August 14, 2018
Publication date:
December 3, 2020
Applicants:
ANTIDOTE THERAPEUTICS, INC., BliNK BIOMEDICAL, Hennepin Healthcare Research Institute
Inventors:
Matthew W. KALNIK, Thomas THISTED, Nicola BELTRAMINELLI, Stéphanie FALLOT, Zuzana BIESOVA, Steve FULLER, Mark G. LESAGE, Paul PENTEL